The Patent Finder

Lilly ICOS LLC

Also on record
Records under this name other than patents Lilly ICOS LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Lilly ICOS LLC

PatentTitleStatus Expires Confidence
US 7,550,479Modified Pictet-Spengler reaction and products prepared therefrom
Formerly held
Term ended
Term ended Nov 17, 2024 · From the USPTO record
Term endedTerm ended Nov 17, 2024From the USPTO record
US 6,821,975Beta-carboline drug products
Formerly held
Term ended
Term ended Nov 6, 2022 · From the USPTO record
Term endedTerm ended Nov 6, 2022From the USPTO record
US 6,841,167β-carboline pharmaceutical compositions
Formerly held
Term ended
Term ended Apr 26, 2020 · From the USPTO record
Term endedTerm ended Apr 26, 2020From the USPTO record
US 6,943,166Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
Formerly held
Term ended
Term ended Apr 26, 2020 · From the USPTO record
Term endedTerm ended Apr 26, 2020From the USPTO record
US 7,182,958β-carboline pharmaceutical compositions
Formerly held
Term ended
Ended no later than Apr 26, 2020 · From the USPTO record
Term endedEnded no later than Apr 26, 2020From the USPTO record
US 7,115,621Chemical compounds
Formerly held
Lapsed on the fee record
Ended Oct 3, 2018 · From the USPTO record
Lapsed on the fee recordEnded Oct 3, 2018From the USPTO record
US 6,911,542Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives
Formerly held
Lapsed on the fee record
Ended Jun 28, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jun 28, 2017From the USPTO record
US 7,122,554Carboline derivatives
Lapsed on the fee record
Ended Oct 17, 2014 · From the USPTO record
Lapsed on the fee recordEnded Oct 17, 2014From the USPTO record
US 6,462,047Carboline derivatives as cGMP phosphodiesterase inhibitors
Formerly held
Lapsed on the fee record
Ended Oct 8, 2014 · From the USPTO record
Lapsed on the fee recordEnded Oct 8, 2014From the USPTO record
US 7,105,506Tetracyclic compounds as PDE5-inhibitors
Lapsed on the fee record
Ended Sep 12, 2014 · From the USPTO record
Lapsed on the fee recordEnded Sep 12, 2014From the USPTO record
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited